Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).

MLA

Eshleman, Susan H., et al. “Characterization of Nevirapine Resistance Mutations in Women with Subtype A vs. D HIV-1 6-8 Weeks after Single-Dose Nevirapine (HIVNET 012).” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 35, no. 2, Feb. 2004, pp. 126–30. EBSCOhost, https://doi.org/10.1097/00126334-200402010-00004.

APA

Eshleman, S. H., Guay, L. A., Mwatha, A., Brown, E. R., Cunningham, S. P., Musoke, P., Mmiro, F., & Jackson, J. B. (2004). Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012). Journal of Acquired Immune Deficiency Syndromes (1999), 35(2), 126–130. https://doi.org/10.1097/00126334-200402010-00004

Chicago

Eshleman, Susan H, Laura A Guay, Anthony Mwatha, Elizabeth R Brown, Shawn P Cunningham, Philippa Musoke, Francis Mmiro, and J Brooks Jackson. 2004. “Characterization of Nevirapine Resistance Mutations in Women with Subtype A vs. D HIV-1 6-8 Weeks after Single-Dose Nevirapine (HIVNET 012).” Journal of Acquired Immune Deficiency Syndromes (1999) 35 (2): 126–30. doi:10.1097/00126334-200402010-00004.